Equities analysts expect that Prestige Consumer Healthcare Inc (NYSE:PBH) will announce earnings per share (EPS) of $0.63 for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Prestige Consumer Healthcare’s earnings, with estimates ranging from $0.62 to $0.63. Prestige Consumer Healthcare posted earnings of $0.61 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 3.3%. The firm is expected to report its next earnings report before the market opens on Thursday, November 1st.

According to Zacks, analysts expect that Prestige Consumer Healthcare will report full year earnings of $2.86 per share for the current fiscal year, with EPS estimates ranging from $2.83 to $2.90. For the next year, analysts anticipate that the firm will post earnings of $3.06 per share, with EPS estimates ranging from $2.97 to $3.17. Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, August 2nd. The company reported $0.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.01. The company had revenue of $253.98 million for the quarter, compared to the consensus estimate of $253.70 million. Prestige Consumer Healthcare had a return on equity of 12.45% and a net margin of 32.76%. The firm’s revenue was down 1.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.66 EPS.

PBH has been the topic of several recent analyst reports. Zacks Investment Research lowered Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 10th. ValuEngine raised Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research note on Thursday, October 11th. Finally, Jefferies Financial Group set a $38.00 target price on shares of Prestige Consumer Healthcare and gave the company a “hold” rating in a research report on Thursday, August 2nd. Two analysts have rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. Prestige Consumer Healthcare presently has an average rating of “Hold” and an average price target of $71.40.

Hedge funds and other institutional investors have recently made changes to their positions in the company. State of Wisconsin Investment Board raised its stake in Prestige Consumer Healthcare by 3.2% during the 2nd quarter. State of Wisconsin Investment Board now owns 54,400 shares of the company’s stock worth $2,088,000 after buying an additional 1,700 shares during the period. Bank of Montreal Can raised its position in shares of Prestige Consumer Healthcare by 135.9% during the second quarter. Bank of Montreal Can now owns 3,067 shares of the company’s stock worth $118,000 after purchasing an additional 1,767 shares during the period. Mutual of America Capital Management LLC raised its position in shares of Prestige Consumer Healthcare by 4.6% during the second quarter. Mutual of America Capital Management LLC now owns 45,518 shares of the company’s stock worth $1,747,000 after purchasing an additional 2,018 shares during the period. US Bancorp DE raised its position in shares of Prestige Consumer Healthcare by 25.8% during the second quarter. US Bancorp DE now owns 10,635 shares of the company’s stock worth $409,000 after purchasing an additional 2,181 shares during the period. Finally, State Board of Administration of Florida Retirement System raised its position in shares of Prestige Consumer Healthcare by 9.7% during the second quarter. State Board of Administration of Florida Retirement System now owns 30,263 shares of the company’s stock worth $1,161,000 after purchasing an additional 2,680 shares during the period.

Shares of NYSE:PBH opened at $36.30 on Tuesday. The stock has a market capitalization of $1.94 billion, a PE ratio of 14.07, a price-to-earnings-growth ratio of 1.87 and a beta of 1.09. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.37 and a current ratio of 2.21. Prestige Consumer Healthcare has a 1 year low of $27.84 and a 1 year high of $48.24.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Story: How does inflation affect different investments?

Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.